Comparison 16. Isepamicin and antianaerobes versus amikacin and antianaerobes.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Clinical success	1	205	Odds Ratio (M‐H, Random, 95% CI)	0.62 [0.21, 1.77]
1.1 Overall	1	205	Odds Ratio (M‐H, Random, 95% CI)	0.62 [0.21, 1.77]
2 Clinical success (ITT analysis)	1	267	Odds Ratio (M‐H, Random, 95% CI)	0.42 [0.17, 1.07]
2.1 Overall	1	267	Odds Ratio (M‐H, Random, 95% CI)	0.42 [0.17, 1.07]
3 Microbiological success	1	205	Odds Ratio (M‐H, Random, 95% CI)	0.95 [0.47, 1.92]
4 Wound infection	1	205	Odds Ratio (M‐H, Random, 95% CI)	0.60 [0.18, 2.06]
5 Superinfection	1	205	Odds Ratio (M‐H, Random, 95% CI)	0.77 [0.13, 4.74]
6 Adverse reactions (ITT analysis)	1	267	Odds Ratio (M‐H, Random, 95% CI)	0.88 [0.37, 2.07]
6.1 Overall	1	267	Odds Ratio (M‐H, Random, 95% CI)	0.88 [0.37, 2.07]